16 Jun 2020 12:51
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Mr P Thomson | ||||
b) | Position/status | President, Global Affairs | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 | ||||
b) | Nature of the transaction | Acquisition of Ordinary Shares following the exercise of options granted on 30 November 2016 at the option price of £12.95 per Ordinary Share under the Company's ShareSave Plan. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | N/A (single transaction) | ||||
e) | Date of the transaction | 2020-06-12 | ||||
f) | Place of the transaction
| London Stock Exchange (XLON) | ||||
Glaxosmithkline (GSK)